The brokers need to factor this information into their valuation of the stock. It's an open playing field now, VLA is a definite target. To my knowledge, NSCLC treatment with Optivo was a lot of what the drug valuation was being based on!
- Forums
- ASX - By Stock
- VLA
- How Merck Caused Bristol-Myers' Plunge
How Merck Caused Bristol-Myers' Plunge, page-10
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)